Exhibit
31.1                      CERTIFICATION





I, Kelly
T. Hickel, Chief Executive Officer of TheraBiogen, Inc. (the
"Company" or "Registrant) certify that:





1. I have
reviewed this quarterly report on Form 10-Q of the Company;





2. Based
on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this quarterly
report;





3. Based
on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the Registrant as
of, and for, the periods presented in this quarterly report;





4. The
registrant's other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and
have:





(a)
Designed such disclosure controls and procedures, or


caused
such disclosure controls and procedures to be designed


under
my supervision, to ensure that material information


relating
to the registrant, is made known to us by others within


Company,
particularly during the period in which this report is


being
prepared;


(b)
Designed such internal control over financial


reporting,
or caused such internal control over financial


reporting
to be designed under our supervision, to provide


reasonable
assurance regarding the reliability of financial


reporting
and the preparation of financial statements for


external
purposes in accordance with generally accepted


accounting
principles;


(c)
Evaluated the effectiveness of the registrant's


disclosure
controls and procedures and presented in this report


our
conclusions about the effectiveness of the disclosure


controls
and procedures, as of the end of the period covered by


this
report based on such evaluation; and


(d)
Disclosed in this report any change in the


registrant's
internal control over financial reporting that


occurred
during the Company's fourth fiscal quarter that has


materially
affected, or is reasonably likely to materially


affect,
the Company's internal control over financial reporting; and





5. The
Registrant's other certifying officers and I have disclosed, based on our most
recent evaluation, to the registrant's auditors and the audit committee
of registrant's board of directors (or persons performing the


equivalent
function):





a.
all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls;





and




b.
any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrant's internal controls;
and





6. The
Registrant's other certifying officers and I have indicated in this annual
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.








Date:
November 10,
2009                  /s/
Kelly T. Hickel


-----------------------------


Kelly T. Hickel,


Chief Executive Officer